Analysts parsed the limited data available for Pfizer’s obesity candidate on the pharma’s fourth-quarter earnings call Tuesday, looking for any nugget of additional context.
In its 2025 full year and fourth-quarter earnings call, Merck executives touted the merits of recent deals and what CEO Robert Davis called “probably the broadest and widest pipeline we’ve had in years.”
After suffering in the wake of expired tax incentives for pharmas, the island is trying to take advantage of geopolitics to grow its drug manufacturing sector.
The Internal Revenue Service posted a contingency plan Friday indicating that it would be able to operate until Feb. 7, 2026, while keeping all 74,942 employees working.
The American Institute of CPAs introduced a new program to identify and develop the skills needed by early-career CPAs to succeed in an AI-driven market.